StockMarketWire.com - Barclays Capital today reaffirms its equal weight investment rating on Mediclinic International Plc [LON:MDC] and cut its price target to 410p (from 460p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk